Bryan Castle is currently the Associate Vice President of Synthetic Molecule Design & Development at Eli Lilly and Company. They have extensive experience in analytical chemistry, having served in various leadership roles, including Executive Director and Senior Research Advisor, where they were responsible for overseeing strategies and teams for small molecule commercialization. Bryan obtained a PhD in Analytical Chemistry from the University of Florida and is currently pursuing a Bachelor of Science in Chemistry at Florida Atlantic University. Their contributions have significantly advanced drug development processes, particularly in oncology and pharmaceutical analytics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices